Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.
Entry Term(s)
Nerve Transmitter Substance
Nerve Transmitter Substances
Neurohormone
Neurohormones
Neurohumor
Neurohumors
Neuromodulator
Neuromodulators
Neuroregulator
Neuroregulators
Neurotransmitter
Neurotransmitter Agent
Neurotransmitters
Substances, Nerve Transmitter
Transmitter Substances, Nerve
Registry Numbers
0
Public MeSH Note
1998; for NEUROTRANSMITTERS see NEUROTRANSMITTERS 1968-2005; NEUROTRANSMITTERS was NEUROREGULATORS 1980-94, was NEUROHUMORS 1968-79, NEUROREGULATORS 1977-94
Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.
Endogenous signaling molecules secreted by neurons that alter the behavior of neurons or effector cells. Neurotransmitter is used here in its most general sense, including not only messengers that act directly to regulate ion channels, but also those that act through second messenger systems, and those that act at a distance from their site of release. Included are neuromodulators, neuroregulators, neuromediators, neurohormones, and neurohumors, whether or not acting at synapses.